The move follows AstraZeneca’s previously announced plan to complete a direct listing of its Ordinary Shares and debt securities on the New York Stock Exchange
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
The company plans to raise US $ 15 million
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
Tamir brings more than 20 years of experience in the medical technology sector
As of December 31, 2025, the company reported total cash, cash equivalents and short-term investments of approximately $4.94 million
Cidara will become a wholly owned subsidiary of Merck and the common stock of Cidara will no longer be listed or traded on the Nasdaq Global Market
Akero became a wholly owned subsidiary of Novo Nordisk
Subscribe To Our Newsletter & Stay Updated
